节点文献

历代成方制剂及现代临床处方中细辛用量的调查与分析

The Investigation and Analysis on the Dosage of Herba Asari in the Historical Preparations and the Present Clinical Prescriptions

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张志国谈发金曹臣邓桂明

【Author】 ZHANG Zhi-guo 1,TAN Fa-jin 2,CAO Chen 1,DEN Gui-ming 1 (1 The First affiliated Hospital of the Hunan College of Chinese Traditional Medicine,Changsha 410007,China; 2 Hunan Goldprise Pharmaceutical Development Co.Ltd,Changsha 410008,China)

【机构】 湖南中医学院第一附属医院湖南普生医药开发有限公司湖南中医学院第一附属医院 湖南长沙410007湖南长沙410008湖南长沙410007湖南长沙410007

【摘要】 目的 :了解历代成方制剂及现代临床处方中细辛的用量。方法 :调查了《方剂学》、现行《药典》中的成方、临床中药汤剂含有细辛的处方。结果 :古、近代多数处方中细辛的用量是现行《药典》上限用量的 6倍~ 14倍 ;临床汤剂处方在《药典》范围内的占 4 7 5 %。结论 :古、近代、现代临床处方中细辛用量与现行《药典》规定的用量相距甚远。

【Abstract】 OBJECTIVE: To comprehend the dosage of Herba Asari in the historical preparations and the present clinical prescriptions. METHODS:To investigate the prescriptions of TCM,The present pharmacopoeia and the clinical decoction prescriptions which comprise Herba Asari. RESULTS:The dosage of Herba Asari in ancient and modern times prescriptions is as six to fourteen times as the maximum of the present pharmacopoeia. It comprises 47.5% that the clinical prescriptions which dosage is in the scope of pharmacopoeia. CONCLUSION: The dosage of Herba Asari in ancient,modern and present times prescriptions is far away from the regulation dosage of pharmacopoeia.

  • 【文献出处】 中国实验方剂学杂志 ,Chinese Journal of Experimental Traditional Medical Formulae , 编辑部邮箱 ,2003年06期
  • 【分类号】R289.5
  • 【被引频次】9
  • 【下载频次】189
节点文献中: 

本文链接的文献网络图示:

本文的引文网络